reviewNew England Journal of MedicineSep 4, 2019GREEN OA

Immune Thrombocytopenia

NCNichola CooperWGWaleed Ghanima

Hammersmith Hospital · Imperial College London · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Immune thrombocytopenia in patients who present with serious bleeding is treated with platelet transfusions, glucocorticoids, and intravenous immune globulin. In patients without serious bleeding, treatment decisions are guided by the platelet count and other factors. Commonly used agents include glucocorticoids, thrombopoietin-receptor agonists, and rituximab.

Citation impact

479
total citations
FWCI
32.20
Percentile
100%
References
53
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Medicine
  • Immune thrombocytopenia
  • Thrombopoietin
  • Rituximab
  • Platelet
  • Thrombopoietin receptor
  • Immune system
  • Romiplostim
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.